TESSITORE, SARA
 Distribuzione geografica
Continente #
EU - Europa 723
AS - Asia 221
NA - Nord America 98
SA - Sud America 15
AF - Africa 1
Totale 1.058
Nazione #
IT - Italia 696
US - Stati Uniti d'America 90
SG - Singapore 81
CN - Cina 63
VN - Vietnam 48
HK - Hong Kong 11
BR - Brasile 9
GB - Regno Unito 6
MX - Messico 6
AR - Argentina 5
DE - Germania 4
FR - Francia 4
IN - India 3
FI - Finlandia 2
IL - Israele 2
JP - Giappone 2
PH - Filippine 2
PL - Polonia 2
SA - Arabia Saudita 2
AT - Austria 1
BD - Bangladesh 1
CA - Canada 1
CH - Svizzera 1
DZ - Algeria 1
ES - Italia 1
ID - Indonesia 1
IE - Irlanda 1
IQ - Iraq 1
KZ - Kazakistan 1
LT - Lituania 1
MT - Malta 1
MY - Malesia 1
NL - Olanda 1
OM - Oman 1
PK - Pakistan 1
PY - Paraguay 1
RU - Federazione Russa 1
SE - Svezia 1
SV - El Salvador 1
Totale 1.058
Città #
Genoa 535
Vado Ligure 106
San Jose 44
Singapore 37
Ho Chi Minh City 16
Beijing 12
Hanoi 11
Hong Kong 11
Messina 6
Da Nang 5
Orem 5
Rome 5
Bari 4
Chicago 4
Haiphong 4
Mexico City 4
Castellana Grotte 3
Lauterbourg 3
Los Angeles 3
Milan 3
New York 3
Pisa 3
São Paulo 3
Ashburn 2
Avezzano 2
Berlin 2
Brooklyn 2
Buffalo 2
Council Bluffs 2
Helsinki 2
Naples 2
Tel Aviv 2
Warsaw 2
Ahmedabad 1
Algiers 1
Amsterdam 1
Aparecida de Goiânia 1
Atlanta 1
Baguio City 1
Biên Hòa 1
Bordighera 1
Bắc Ninh 1
Casilda 1
Caucaia 1
Cedar Rapids 1
City of London 1
Ciudad del Este 1
Columbus 1
Culpeper 1
Córdoba 1
Dallas 1
Don Torcuato 1
Dublin 1
Florence 1
Foshan 1
Fragagnano 1
Frankfurt am Main 1
Guaiçara 1
Hải Dương 1
Itapeva 1
Jeddah 1
Karnāl 1
Krasnodar 1
Kuala Lumpur 1
Lomas de Zamora 1
London 1
Lấp Vò 1
L’Aquila 1
Madrid 1
Muscat 1
Nam Định 1
Olímpia 1
Paris 1
Pénjamo 1
Querétaro 1
Rafael Castillo 1
Rawalpindi 1
Riyadh 1
San Salvador 1
Semey 1
Sylhet 1
Tampa 1
Tarlac City 1
Temecula 1
Thái Bình 1
Tokyo 1
Toronto 1
Turin 1
Valletta 1
Varginha 1
Vienna 1
Xi'an 1
Yancheng 1
Zhengzhou 1
Zurich 1
Totale 912
Nome #
The complex phenotype and function of spinal cord microglia during ALS progression and the impact of metabotropic glutamate receptor type 5 down-regulation in SOD1G93A mice 147
Genetic Downregulation of the Metabotropic Glutamate Receptor Type 5 Dampens the Reactive and Neurotoxic Phenotype of Adult ALS Astrocytes 108
mGlu5 receptor negative allosteric modulation reduces the aberrant cellular reactivity and neurotoxicity of reactive human astrocytes differentiated from fibroblast of SOD1 and C9orf72 ALS patients 106
Genetic and pharmacological effects by blocking mGlu5 receptor in the SOD1G93A mouse model of amyotrophic lateral sclerosis 105
Preclinical study showing a gender specific protective properties of conjugated linoleic acid (CLA) for amyotrophic lateral sclerosis 105
mGlu5 receptor negative allosteric modulation reduces the aberrant cellular reactivity and neurotoxicity of iNPCs-derived human astrocytes differentiated from ALS patients 80
Reactive Astrocytes from patients affected by Amyotrophic Lateral Sclerosis: how mGlu5 receptor modulation affects pathological features 72
The mGlu5 receptor negative allosteric modulator CTEP as a pharmacological tool to dampen ALS disease progression: in-vivo preclinical studies and clinical perspectives 69
The negative allosteric modulator CTEP ameliorates the reactive phenotype of iastrocytes from patients affected by Amyotrophic Lateral Sclerosis 56
Preventive effects of conjugated linoleic acid (CLA) in-vivo oral treatment in the SOD1G93A preclinical model of amyotrophic lateral sclerosis 56
Reactive phenotype and oxidative stress in i-Astrocytes from patients affected by Amyotrophic Lateral Sclerosis: how the mGluR5 negative allosteric modulator CTEP affects these pathological features 51
The negative allosteric modulator CTEP ameliorates the reactive phenotype of human-derived iAstrocytes differentiated from iNPCs of patients affected by Amyotrophic Lateral Sclerosis 51
The negative allosteric modulator CTEP ameliorates the reactive phenotype of iastrocytes from patients affected by Amyotrophic Lateral Sclerosis 48
In-vitro study on human-derived astrocytes showed the effects of mGluR5 negative allosteric modulator CTEP in reducing the aberrant activation and neurotoxicity of astroglial cells in ALS 10
Focus on the excitatory and inhibitory neurotransmission imbalance in amyotrophic lateral sclerosis: a harmful disease player or a potential therapeutic opportunity? 8
The mGluR5 negative allosteric modulator CTEP reduces the aberrant activation and neurotoxicity of human-derived astrocytes differentiated from fibroblasts of ALS patients 8
Totale 1.080
Categoria #
all - tutte 2.936
article - articoli 603
book - libri 0
conference - conferenze 2.166
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.705


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202468 0 5 1 3 1 3 1 1 0 9 19 25
2024/2025320 17 13 3 20 33 31 30 57 20 24 40 32
2025/2026692 72 37 100 72 92 36 84 49 52 98 0 0
Totale 1.080